Day: March 10, 2021

CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2021 Annual Meeting

ZUG, Switzerland and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that it will present a poster at the American Association for Cancer Research (AACR) Annual Meeting, to be held in a virtual format from April 10 to 15 and May 17 to 21, 2021.Title: CD70 knockout: A novel approach to augment CAR-T cell functionSession Title: Adoptive Cell TherapySession Category: ImmunologyAbstract Number: 1537, e-posterDate and Time: Saturday, April 10, 2021, 8:30 a.m. ET via the AACR website, www.aacr.orgAbout CRISPR TherapeuticsCRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9...

Continue reading

Shawcor Ltd. Announces Fourth Quarter 2020 Results

Fourth quarter 2020 revenue was $326 million, 3% lower than the $334 million reported in the fourth quarter of 2019.Adjusted EBITDA1 in the fourth quarter of 2020 was $46 million, 56% higher than the $30 million reported in the fourth quarter of 2019. The current quarter includes $6 million of COVID-19 related government wage subsidies.During the fourth quarter of 2020, the Company sold its Pipeline Performance Products business and recorded a gain of $52 million.Net Income2 in the fourth quarter of 2020 was $56 million (or earnings per share of $0.79 diluted) compared with a net loss of $82 million (or loss per share of $1.17 diluted) in the fourth quarter of 2019. Excluding the impact of impairment charges, restructuring costs, gains on the sale of land and other, investment in associates, and operating unit and the adjustment for Argentina...

Continue reading

MannKind Corporation to Participate in Oppenheimer’s 31st Annual Healthcare Conference

WESTLAKE VILLAGE, Calif., March 10, 2021 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that its Chief Executive Officer, Michael Castagna, PharmD, will participate in a Fireside Chat at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 1:50 pm (ET). Interested parties can access a link to the webcast from the Events & Presentations section of the Company’s website at http://www.mannkindcorp.com. The webcast replay will remain available for 14 days following the live presentation.About MannKind CorporationMannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of inhaled therapeutic products...

Continue reading

ERES REIT and CAPREIT Announce Extension of €165M Pipeline Agreement

TORONTO, March 10, 2021 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX:ERE.UN, “ERES”) and Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN, “CAPREIT”) announced today the extension of the pipeline agreement between ERES and CAPREIT (the “Pipeline Agreement”) for an additional two-year period, ending on March 29, 2023.The Pipeline Agreement, entered on March 29, 2019 following completion of the reverse acquisition that formed ERES, makes up to €165 million (approximately C$248 million) (the “Total Commitment”) available to ERES to acquire properties that comply with ERES’s investment policy, do not contravene the investment policy of CAPREIT and which ERES wishes to purchase but is unable to do so with its own resources. Once any part of the Total Commitment has been repaid, that part...

Continue reading

Currency Exchange International, Corp. Expands by Joining the Jack Henry Banking Vendor Integration Program

ORLANDO, Fla., March 10, 2021 (GLOBE NEWSWIRE) — Currency Exchange International, Corp. (TSX:CXI) (OTCBB:CURN), a full service foreign exchange technology and services provider, today announced that it has joined the Jack Henry Banking® Vendor Integration Program (VIP). Participation in the program will provide CXI with access to Jack Henry Banking’s technical resources to enable CXI’s proprietary foreign exchange and payments software, CXIFX, to integrate with SilverLake, CIF 20/20, and Core Director. The Vendor Integration Program is designed to help ensure that Jack Henry Banking’s customers can easily deploy third-party products.CXIFX integrates with SilverLake, CIF 20/20, and Core Director via jXchange™, a services-based programming interface that enables third-party vendors and banks to access the platform’s core data and...

Continue reading

HighPeak Energy, Inc. to Release Fourth Quarter 2020 Earnings on Monday, March 15, 2021

FORT WORTH, Texas, March 10, 2021 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (NASDAQ: HPK) (“HighPeak Energy”), today announced that it plans to release fourth quarter 2020 and full year operational and financial results after the close of trading on Monday, March 15, 2020.HighPeak Energy will host a conference call and webcast on Thursday, March 18, 2021 at 10:00 a.m. Central Time for investors and analysts to discuss its results for the fourth quarter and full year of 2020 as well as provide an overview of recent activities and its 2021 operating plan. Conference call participants may call (833) 362-0226 (United States/Canada) or (914) 987-7683 (International) and enter confirmation code 2656449. A live broadcast of the earnings conference call will also be available on the HighPeak Energy’s website at www.highpeakenergy.com under...

Continue reading

Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting

CAMBRIDGE, Mass. and NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that pre-clinical data on BDTX-189 and BDTX-1535 will be presented as late-breaking poster presentations at the American Association for Cancer Research (AACR) Virtual Annual Meeting, taking place April 10-15, 2021.Presentation details are as follows:Title: Prospective pre-clinical modeling to estimate clinical pharmacokinetics and doses of BDTX-189, an inhibitor of allosteric ErbB mutations in advanced solid malignanciesSession Type: E-Poster SessionSession Category: Experimental and Molecular TherapeuticsSession Title: Pharmacology, Pharmacogenetics, and PharmacogenomicsDate and...

Continue reading

Advanced Emissions Solutions Reports Fourth Quarter and Full Year 2020 Results

HIGHLANDS RANCH, Colo., March 10, 2021 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”) today filed its Annual Report on Form 10-K and reported financial results for the fourth quarter and full year ended December 31, 2020, including information about its equity investment in Tinuum Group, LLC (“Tinuum Group”) and Tinuum Services, LLC (“Tinuum Services”) (collectively “Tinuum”), of which ADES owns 42.5% and 50%, respectively.Tinuum & Refined Coal (“RC”) HighlightsTinuum’s fourth quarter distributions to ADES totaled $20.2 million compared to $17.1 million in the prior year. Full year distributions totaled $62.4 million compared to $73.9 million in 2019Royalty earnings from Tinuum Group were $3.5 million for the fourth...

Continue reading

Wesdome Announces 2020 Fourth Quarter and Full Year Financial Results

TORONTO, March 10, 2021 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO) (“Wesdome” or the “Company”) (“Q4 2020”) and full year 2020 financial results.   The Company’s full consolidated financial statements and management discussion & analysis are available on SEDAR at www.sedar.com and on the Company’s website at www.wesdome.com. All figures are stated in Canadian dollars unless otherwise noted.Key highlights of 2020:Production of 90,278 ounces.Company free cash flow1generation of $29.0 million, net of investing $40.5 million into the Kiena Complex, an increase of 332% over 2019.Net income increased by 24% from 2019 and adjusted net income1increased by 31% from 2019.Operating cash flow increased by 44% from 2019.Increased Eagle River Reserves by 5% net of 93,132 ounces of depletion.Increased Eagle River inferred Resources...

Continue reading

Churchill Downs Incorporated Announces Pricing of $300 Million Senior Secured Term Loan B due 2028 and $200 million Senior Notes due 2028

LOUISVILLE, Ky., March 10, 2021 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or the “Company”) (Nasdaq: CHDN) today announced that it successfully priced its previously announced offering of $200 million in aggregate principal amount of its 4.75% senior notes due 2028 (the “Additional Notes”). In addition, CDI announced the pricing of a $300 million senior secured Term Loan B (the “Term Loan B”) due 2028. The Additional Notes were priced at 103.25% of the principal amount and the Term Loan B was priced at LIBOR plus 200 basis points.The offering of the Additional Notes is expected to close on March 17th, 2021, and the Term Loan B is expected to close concurrently with the Additional Notes, subject to customary closing conditions.The Additional Notes will be issued as additional notes under an indenture...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.